This content is machine translated ASCO 2017 in Chicago Groundbreaking on tumors of the prostate and gallbladder There was big news at the 2017 ASCO Congress. First, abiraterone is pushing into the first-line setting in metastatic prostate cancer. On the other hand, there is a new standard…
